Glimepiride, an oral sulfonylurea, stimulates insulin production; unlike insulin injections, it is easier to administer and manage for some patients. Best used for type 2 diabetes not controlled by diet and exercise alone.

Compared to insulin, Glimepiride, taken orally, is less invasive and can improve compliance. It’s particularly beneficial in type 2 diabetes patients who struggle with self-administering insulin.

Glimepiride triggers insulin release from the pancreas, which is simpler for patient administration than insulin injections. However, it’s generally less effective in advanced type 1 diabetes.